Description
PD-L1 regulates immune responses by binding to the immunoinhibitory receptor PD-1 on activated T-cells and B-cells. This interaction can suppress T-cell responses by inducing apoptosis and arresting cell-cycle progression. In cancer, PD-L1's role in reducing antigen-specific T cells can promote tumor growth and immune evasion. As a result, PD-L1 is considered as a potential therapeutic target for autoimmune diseases and cancer.
Species of Origin
Human
Expression system
HEK293
Affinity Tag
His Tag (C-term)
Buffer
Lyophilized from a 0.2 µm filtered solution of PBS, pH 7.4.
Purity
>95% as determined by SDS-PAGE analysis.
Molecular weight
The protein has a calculated MW of 26 kDa.
The protein migrates as 30-35 kDa uder reducing condition (SDS-PAGE analysis).
Activity
Measure by its ability to induce adhesion in T-cell enriched PBMC cultures using a concentration range of 1-2 μg/mL.
Endotoxin level
<0.1 EU per 1 μg of the protein by the LAL method.
Form
Lyophilized
Background
Programmed death-ligand 1 (PD-L1) is an immune checkpoint protein expressed on various cell types, including tumor cells. It interacts with PD-1 on T cells to suppress immune responses, enabling tumor immune evasion. Recombinant PD-L1 with a His tag, expressed in HEK293 cells, is crucial for studying PD-1/PD-L1 interactions, developing immune checkpoint inhibitors, and conducting functional assays in cancer immunotherapy research. The use of HEK293 cells ensures proper folding and post-translational modifications, maintaining biological activity.
Synonyms
CD274, B7-H1
Uniprot ID
Q9NZQ7.1
Sequence Note
Phe19-Arg238
Reconstitution
It is recommended to reconstitute the lyophilized protein in sterile H₂O to a concentration of 200 μg/mL and incubate the stock solution for at least 20 min to ensure sufficient re-dissolved.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at -20°C or lower for long term storage.
Stability & Storage
This product is stable after storage at:
Avoid repeated freeze/thaw cycles.
SDS-PAGE analysis of recombinant human PD-L1.
Measure by its ability to induce adhesion in T-cell enriched PBMC cultures using a concentration range of 1-2 μg/mL.
The ED₅₀ for this effect is 1.3 μg/mL.
Help others learn more about this product. Use the link below to share your experience.
There are currently no publications. Use the link below to let us know.
Disclaimer：For Research Use or Further Manufacturing Only.
最後更新：
